Corinne Lee-Kubli

Corinne Lee-Kubli has been working in the field of technology development and CNS drug discovery since 2020, when they began their role as Associate Director of Technology Development & CNS Drug Discovery at DTx Pharma. Prior to this, they were a Postdoctoral Researcher at the Salk Institute for Biological Studies from 2017 to 2020 and a Post-doctoral fellow at UC San Diego from 2013 to 2017.

Corinne Lee-Kubli obtained their B.S. in Neuroscience from the University of California, Los Angeles in 2006. Corinne then went on to pursue a PhD in Molecular Medicine from the Sanford Burnham Institute Graduate Program from 2007 to 2011.